Exsilio Therapeutics announced it raised $43.8 Million in an amended filing from an offering of $85 Million
Exsilio Therapeutics announced it raised $43.8 Million in an amended filing from an offering of $85 Million
04/21/25, 7:45 PM
Location
Money raised
$43.8 million
Industry
health care
Company Info
Location
134 coolidge avenue
watertown, massachusetts, united states
Additional Info
Averna Therapeutics Inc. was formerly known as Exsilio Therapeutics Inc. Averna Therapeutics is a biotechnology company developing Ribonucleic acid (RNA) and lipid nanoparticle (LNP)-based genomic medicines to durably and safely treat a broad range of diseases, including genetic diseases, cancer, and autoimmune conditions.